SOURCE: Medical Care Technologies, Inc.

January 20, 2010 07:30 ET

Medical Care Technologies Inc. Continues Technological Development of HVS as Add-On

LONDON--(Marketwire - January 20, 2010) - Medical Care Technologies Inc. (OTCBB: MDCE) today announced that it has been developing its latest medical device technology -- Heart Vital Signs ("HVS") to be included as an add-on to its Tele-Health™ Suite. Remote cardiac monitoring technologies allow home electrocardiographic (ECG) monitoring of patients with suspected cardiac arrhythmias or at risk for developing arrhythmias.

Management believes that by adding the HVS function to its Tele-Health™ technology, caregivers will be able to monitor a patient's cardiac function, no matter where the patient is located. By using an embedded SIM card which connects to a cellular network, streaming signals are transmitted to a remote server whereby physicians or caregivers, through Tele-Health™ Suite, may access and monitor the patient's heart.

MDCE's HVS is simple and easy to use with non-invasive sensors attached to the skin for patient comfort and fast recognition of cardiac and respiratory readings. The HVS is a small, portable physiological monitor that includes a receiver which wirelessly receives the patient's physiological measurements.

According to the World Health Organization (2009 Update), cardiovascular failure is the leading cause of death in the world. In China, data sources suggest that there are between 1 million and 1.5 million stroke deaths per year, and approximately 600,000 more deaths from heart disease. Altogether, cardiovascular failure probably claims about 2.5 million lives -- or almost 30% of all deaths in China -- each year.

MDCE's President, Ning Wu, commented, "We are pleased with our team's efforts in searching for solutions to better care for and monitor a patient's heart. We believe that once our HVS technology is fully developed, physicians and caregivers alike will be able to provide the best possible remote monitoring for cardiology practices, hospitals and nursing homes, ambulatory electrocardiography and home-care services. We are hopeful that HVS will be available to the Chinese market in the near future."

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers -- in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company's website at www.medicaretech.com

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC's assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC's designees in order to close the acquisition. Accounting for the anticipated cancellation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition.

Contact Information